1. Use of proteomic patterns in serum to identify ovarian cancer;Petricoin;Lancet,2002
2. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men;Adam;Cancer Res.,2002
3. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry;Cazares;Clin. Cancer Res.,2002
4. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients;Qu;Clin. Chem.,2002
5. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism;Naylor;J. Child Neurol.,1999